Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
7.61
-0.04 (-0.52%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Vir Biotechnology Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Vir Biotechnology stock have an average target of 36.8, with a low estimate of 12 and a high estimate of 110. The average target predicts an increase of 383.57% from the current stock price of 7.61.
Analyst Consensus: Buy
* Price targets were last updated on Aug 20, 2024.
Analyst Ratings
The average analyst rating for VIR stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $110 | Strong Buy | Reiterates | $110 | +1,345.47% | Aug 20, 2024 |
| Barclays | Barclays | Buy Maintains $27 → $28 | Buy | Maintains | $27 → $28 | +267.94% | Aug 2, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $12 → $15 | Hold | Maintains | $12 → $15 | +97.11% | Jun 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $110 | Strong Buy | Reiterates | $110 | +1,345.47% | Jun 5, 2024 |
| Needham | Needham | Strong Buy Maintains $15 → $19 | Strong Buy | Maintains | $15 → $19 | +149.67% | Jun 5, 2024 |
Financial Forecast
Revenue This Year
71.63M
from 86.18M
Decreased by -16.89%
Revenue Next Year
32.76M
from 71.63M
Decreased by -54.26%
EPS This Year
-3.42
from -4.59
EPS Next Year
-3.81
from -3.42
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 126.6M | 111.5M | 115.9M | ||
| Avg | 71.6M | 32.8M | 44.9M | ||
| Low | 58.3M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 46.9% | 55.7% | 253.8% | ||
| Avg | -16.9% | -54.3% | 37.2% | ||
| Low | -32.3% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.20 | -3.00 | -2.16 | ||
| Avg | -3.42 | -3.81 | -3.67 | ||
| Low | -4.06 | -5.02 | -5.66 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.